ELAB

PMGC Holdings Inc. (ELAB) stock has experienced significant volatility and a substantial decline over the past year, reaching its all-time low of $1.62 on March 26, 2026. Recent events include reporting 2025 annual results with a 43% increase in asset base, Northstrive Biosciences executing a license agreement with Modulant Biosciences LLC, PMGC Holdings tapping its full $20M equity facility, signing a long-term agreement to supply aerospace and defense components, securing up to a $40M equity line, NorthStrive Biosciences filing a new U.S. patent application, and PMGC Holdings boosting its equity plan to 1.11M shares and authorizing 1.5B stock.